gemtuzumab ozogamicinInotuzumab ozogamicinAZD2014gemtuzumab ozogamicin-inducedIOKobe UniversityB-cell non-Hodgkin lymphomaB-cell acute lymphoblastic leukemiaB-cell NHLdiffuse large B-cell lymphoma (DLBCL)
…t al. An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function. Leuk Res. 2018 Nov;74:68–7…